Cisplatin in cancer therapy: molecular mechanisms of action.

Dasari S, Tchounwou PB.

Open source

DOI
10.1016/j.ejphar.2014.07.025
Published
2014-07-21
Container
Eur J Pharmacol
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ejphar.2014.07.025,
  title = {Cisplatin in cancer therapy: molecular mechanisms of action.},
  author = {Dasari S and  Tchounwou PB.},
  year = {2014},
  journal = {Eur J Pharmacol},
  doi = {10.1016/j.ejphar.2014.07.025},
  url = {https://doi.org/10.1016/j.ejphar.2014.07.025}
}

RIS

TY  - JOUR
TI  - Cisplatin in cancer therapy: molecular mechanisms of action.
AU  - Dasari S
AU  -  Tchounwou PB.
PY  - 2014
JO  - Eur J Pharmacol
DO  - 10.1016/j.ejphar.2014.07.025
UR  - https://doi.org/10.1016/j.ejphar.2014.07.025
ER  - 

APA

S, D., & PB., T. (2014). Cisplatin in cancer therapy: molecular mechanisms of action.. Eur J Pharmacol. https://doi.org/10.1016/j.ejphar.2014.07.025

Source records